ATE212235T1 - Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält - Google Patents

Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält

Info

Publication number
ATE212235T1
ATE212235T1 AT92907987T AT92907987T ATE212235T1 AT E212235 T1 ATE212235 T1 AT E212235T1 AT 92907987 T AT92907987 T AT 92907987T AT 92907987 T AT92907987 T AT 92907987T AT E212235 T1 ATE212235 T1 AT E212235T1
Authority
AT
Austria
Prior art keywords
solid preparation
porous solid
active protein
preparation containing
protein compound
Prior art date
Application number
AT92907987T
Other languages
English (en)
Inventor
Keiji Fujioka
Shigeji Sato
Yoshihiro Takada
Original Assignee
Sumitomo Pharma
Koken Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma, Koken Company Ltd filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of ATE212235T1 publication Critical patent/ATE212235T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92907987T 1991-04-08 1992-04-06 Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält ATE212235T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7499091 1991-04-08
JP7499191 1991-04-08
PCT/JP1992/000420 WO1992017209A1 (en) 1991-04-08 1992-04-06 Porous solid preparation containing physiologically active protein substance

Publications (1)

Publication Number Publication Date
ATE212235T1 true ATE212235T1 (de) 2002-02-15

Family

ID=26416148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907987T ATE212235T1 (de) 1991-04-08 1992-04-06 Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält

Country Status (8)

Country Link
US (1) US5496559A (de)
EP (1) EP0578823B1 (de)
KR (1) KR100225153B1 (de)
AT (1) ATE212235T1 (de)
BR (1) BR9205864A (de)
CA (1) CA2107473A1 (de)
DE (1) DE69232374T2 (de)
WO (1) WO1992017209A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE167057T1 (de) * 1994-03-02 1998-06-15 Akzo Nobel Nv Sublinguales oder bukkales arzneimittel
US6270757B1 (en) 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
GB9421837D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US6656157B1 (en) 1995-04-20 2003-12-02 Acist Medical Systems, Inc. Infinitely refillable syringe
US6099502A (en) * 1995-04-20 2000-08-08 Acist Medical Systems, Inc. Dual port syringe
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
TW403653B (en) * 1995-12-25 2000-09-01 Otsuka Pharma Co Ltd Dry compositions
AU724689B2 (en) 1996-05-09 2000-09-28 Pharma Pacific Pty Ltd Method of treatment
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
FR2769505B1 (fr) * 1997-10-10 2000-06-30 Michael Gerard Tovey Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations
IL143356A0 (en) * 1998-11-27 2002-04-21 Takada Kanji An oral formulation for gastrointestinal drug delivery
SE514342C2 (sv) * 1999-05-31 2001-02-12 Nobel Biocare Ab Metod, anordning och användning vid implantat för att tillförsäkra tillförsel av bioaktiv substans till implantatets omgivande ben och/eller vävnad
US6626862B1 (en) 2000-04-04 2003-09-30 Acist Medical Systems, Inc. Fluid management and component detection system
US20040028738A1 (en) * 2000-10-05 2004-02-12 Lynn L.H. Huang Process for the preparation of porous collagen matrix
US7098315B2 (en) 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
EE05685B1 (et) * 2001-01-25 2013-12-16 Nycomed Pharma As Fibrinogeeni, trombiini ja alkoholi sisaldav suspensioon ning meetod kandja katmiseks selle suspensiooniga
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
EP1917982B1 (de) * 2006-11-06 2010-04-21 Lohmann & Rauscher GmbH & Co. KG Produkt zur Versorgung von Entzündungen, Druckstellen und/oder Aphten im Oralbereich sowie Verwendung eines solchen Produkts
JP5723531B2 (ja) * 2010-01-20 2015-05-27 Ｄｓファーマアニマルヘルス株式会社 チューブ内に保持された凍結乾燥製剤
CN102357259A (zh) * 2011-07-28 2012-02-22 王珊珊 一种生物蛋白海绵及其制备方法
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
JPS6097918A (ja) * 1983-11-01 1985-05-31 Sumitomo Chem Co Ltd インタ−フエロン持続性製剤
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine
ATE87469T1 (de) * 1985-12-27 1993-04-15 Sumitomo Pharma Verfahren zur herstellung einer formulierung mit verzoegerter freisetzung.
JPH0725688B2 (ja) * 1986-03-31 1995-03-22 住友製薬株式会社 Ｃｓｆ徐放性製剤
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
JPS63198635A (ja) * 1987-02-12 1988-08-17 Toray Ind Inc エイズ原因ウイルスに対する抗ウイルス剤
DE68907066T2 (de) * 1988-01-29 1993-12-16 Sumitomo Pharma Verbesserte Formulierungen mit kontrollierter Abgabe.
JP2641755B2 (ja) * 1988-01-29 1997-08-20 住友製薬株式会社 コントロールリリース製剤
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤

Also Published As

Publication number Publication date
BR9205864A (pt) 1994-06-28
EP0578823A4 (de) 1994-12-14
DE69232374T2 (de) 2002-08-29
US5496559A (en) 1996-03-05
CA2107473A1 (en) 1992-10-09
EP0578823A1 (de) 1994-01-19
DE69232374D1 (de) 2002-03-14
KR100225153B1 (ko) 1999-10-15
WO1992017209A1 (en) 1992-10-15
EP0578823B1 (de) 2002-01-23

Similar Documents

Publication Publication Date Title
ATE212235T1 (de) Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält
SE8902288D0 (sv) Farmaceutisk komposition
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
SE8804629D0 (sv) New therapeutically active compounds
DK0509317T3 (da) Lægemidler imod knoglesygdomme
FR11C0017I2 (fr) Utilisation de spinosad ou d'une formulation comprennant spinosad
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
EP0768079A4 (de) Mittel zur förderung des haarwachstums
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
ES513159A0 (es) "procedimiento para la preparacion de polipeptidos inmunogenamente activos y producidos microbianamente, para la obtencion de una vacuna contra la fiebre aftosa".
SE8804628D0 (sv) New compounds
IT8622064A0 (it) Caralizzatore di ossidazione eprocedimento per la sua preparazione.
DE50003454D1 (de) Proteinenthaltende pharmazeutische zubereitung
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
HUP9900507A2 (hu) Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmények előállítására
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
DE59008309D1 (de) Fungizide Wirkstoffkombinationen.
NO991740D0 (no) Farmas°ytiske og kosmetiske formuleringer med antimikrobiell aktivitet
RU2001128736A (ru) Способ нормализации воспроизводительной функции коров
IT1229519B (it) Composizione farmaceutica comprendente come ingrediente attivo 3-(n-piperidinometil- azino) metilrifamicina s
ATE62593T1 (de) Physiologisch wirksame und naehrende zusammensetzung.
GB9005316D0 (en) Pharmaceutical composition comprising 3-(n-piperidinomethyl-azino)methylrifamycin s as active ingredient
GB8902069D0 (en) Pharmaceutical composition comprising 3-(n-piperidino-azino)methylrifamycin s as active ingredient

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties